Theralase CEO to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM
March 12 2014 - 7:05AM
Marketwired
Theralase CEO to Be Interviewed Today on Clear Channel Business
Talk Radio DFW 1190AM
Interview Airs at 1:05pm CDT / 11:05am PDT / 2:05pm EDT on The
Traders Network Show, Wednesday, March 12, 2014, Hosted by Michael
Yorba
TORONTO, ON--(Marketwired - Mar 12, 2014) - Theralase
Technologies Inc. (OTCBB: TLTFF) (TSX-VENTURE: TLT) sells patented,
superpulsed laser technology to healthcare practitioners to heal
damaged tissue and eliminate pain. Theralase is also developing the
next generation cancer treatment combining patented light activated
compounds with laser technology to hunt down and destroy
cancer.
Roger Dumoulin-White, President and CEO of Theralase will be
interviewed live by host Michael Yorba on Clear Channel Business
Talk Radio's The Traders Network Show.
In today's exclusive 2-segment interview, Mr. Dumoulin-White
will discuss new developments in their therapeutic laser technology
and how Theralase is breaking new ground researching and developing
patented Photo Dynamic Compounds (PDCs) that have shown an ability
to target and effectively destroy cancer when light activated by
Theralase's patented laser technology.
We encourage all interested investors and prospective customers
across the US to tune in and listen live via Clear Channel's
nationally syndicated iHeart Radio stream.
The live interview details are as follows:
Live Stream via iHeart:
http://www.iheart.com/live/4276/?autoplay=true Date: Wednesday,
March 12, 2014 Start Time: 1:05pm CDT | 11:05am PDT | 2:05pm EDT
(U.S.) Network: Clear Channel Station: DFW 1190AM KFXR Show: The
Traders Network Host: Michael Yorba
About Clear Channel: Clear Channel's Media and Entertainment
division has the largest reach of any radio or television outlet in
America with 243 million monthly listeners. It serves 150 cities
through 850 owned radio stations in the U.S., as well as more than
140 stations in New Zealand and Australia.
www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and
featured host on Clear Channel. For the past six years he has
produced and hosted The Traders Network Show broadcasted live daily
on Clear Channel DFW 1190AM KFXR from 1pm - 3pm CST, Monday-Friday
following the Glenn Beck Show.
Michael Yorba interviews the front-page Titans about the latest
in capital markets, CEO milestones, trading tools, real estate
acquisitions and market trends. Learn how the experts use risk
management techniques to build fully diversified portfolios and
what it takes to put up big board earnings. It's a fast moving,
high-energy show that presents stocks, commodities, bonds, forex,
derivatives, real estate, political trends, technology trends,
crowd funding and impact investment insights in a new light and
keeps audience asking for more... shift your thinking and join us
as we deliver "tomorrow's ideas today" on Clear Channel's The
Traders Network Show.
About Theralase Technologies Inc.: Theralase Technologies Inc.
(OTCBB: TLTFF) (TSX-VENTURE: TLT) designs, manufactures and markets
patented, superpulsed laser technology utilized in effectively
healing damaged tissue by eliminating pain, reducing
inflammation and accelerating healing for a wide range of nerve,
muscle and joint conditions, such as low back pain, knee pain and
neck pain. Theralase is also researching and developing the next
generation cancer treatment with patented Photo Dynamic Compounds
(PDCs) that are able to target and effectively destroy cancer when
light activated by Theralase's patented laser technology.
For further information please visit www.theralase.com,
regulatory filings may be viewed by visiting
www.sedar.com.
This press release contains forward-looking statements,
which reflect the Company's current expectations regarding future
events. The forward-looking statements involve risks and
uncertainties. Actual results could differ materially from those
projected herein. The Company disclaims any obligation to update
these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchanges) accepts responsibility for the adequacy or
accuracy of this release.
A www.1800PublicRelations.com PR Event
For More Information: Roger Dumoulin-White President & CEO
1-866-THE-LASE (843-5273) x 225 416-699-LASE (5273) x 225
rwhite@theralase.com www.theralase.com Press/Media Contact: Matthew
Bird MUNCmedia Public Relations 1-917-409-8211
matt.bird@muncmedia.com www.muncmedia.com
Theralase Technologies (QB) (USOTC:TLTFF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Theralase Technologies (QB) (USOTC:TLTFF)
Historical Stock Chart
From Dec 2023 to Dec 2024
